Key result
COX-2 inhibitors (coxibs) have been increasingly associated with cardiovascular risks in recent reports, prompting significant concern among patients and healthcare professionals.
Answers are grounded in this paper and cite their sources.
Highlights the growing clinical and public concern regarding the cardiovascular risks of COX-2 inhibitors.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Antman et al. (2005) conducted an editorial in Cardiovascular risk associated with antiinflammatory medications. COX-2 inhibitors (coxibs) was evaluated. COX-2 inhibitors (coxibs) have been increasingly associated with cardiovascular risks in recent reports, prompting significant concern among patients and healthcare professionals.
Synapse has enriched 10 related papers. Consider them for comparative context: